Centre for Pharmaceutics
ABOUT US
Welcome to the Centre for Pharmaceutics!
We teach the art of formulating and delivering a drug to its therapeutic site!
Established to pioneer research and training in Pharmaceutical Technology, we are on a mission to become a global leader in drug development. Our focus is on creating cost-effective, cutting-edge delivery systems that enhance medication compliance. In regulatory science domain, we prepare the students to travel through the intersection of science, medicine, and law to protect public health.
Our programs are approved by PCI and UGC, are designed to propel the students to the forefront of the pharmaceutical industry and research.
Our distinguished faculty comprises seasoned professionals with extensive industry acumen, blending real-world experience with academic excellence to mentor and empower students. Spanning from foundational principles to advanced concepts in drug formulation, safety, efficacy, and marketing approval, our curriculum prepares graduates to thrive in the intricate landscape of pharmaceutics domain.
PROGRAMS OFFERED
- M.Pharm (Pharmaceutics)
No of seats = 15 - M.Pharm (Industrial Pharmacy)
No of seats = 15 - M.Pharm (Drug regulatory Affairs)
No of seats = 12
ONGOING PROJECTS
Sl. No. |
Title of the Project |
Funding Agency |
Name of the Faculty |
Amount in Lakhs |
Status |
1 |
Colon targeting of Unani medicine via gum(polysaccharide) based oral formulation for effective treatment of irritable bowel syndrome/clinical investigation by gamma scintigraphy |
CCRUM Ministry of AYUSH |
Dr. Nitin Sharma |
22,41,000 |
Ongoing |
2 |
Instant Wound sealing Gun for Traumatic and combat casualty wounds |
SERB- DST |
PI: Dr. Navneet Sharma Co- PI: Dr. Vikesh Kumar Shukla |
4400000 |
Ongoing |
3. |
"Empowering the steps of the science players wearing science diplomacy shoes" SciPADReC project for India, South Africa and Nepal |
Inter Academy Partnership (IAP) |
Dr. Kalpana Nagpal |
USD 18,800 |
ongoing |
Consultancy Activities
Sl. No |
Name of the faculty |
Study Name |
Sponsoring agent |
Amount in Lakhs |
Status |
1 |
Dr. Nitin Sharma |
Stability study of nasen gel and senotact |
MGCT Noida |
2,95,000/- |
Completed |
RESEARCH SCHOLARS
S.no. | Name of Scholar | Date of Registration | Research Title / Topic | Guide | Current Status |
1 | Mr Pankaj Kumar Sharma | 18-Jan-19 | Formulation and characterization of self nanoemulsifying drug delivery system for oral biovailability enhancement of poorly soluble drugs | Dr. Vikesh Kumar Shukla | Degree Awarded |
2 | Ms Gayatri Khosla | 24-Jan-20 | Phytochemical Investigation and Development of Targeted Drug Delivery System of Plumbago Species for Antifertility Activity. | Dr. Vikesh Kumar Shukla | PrePhD done |
3 | Mr N Raveendra Babu | 04-Sep-20 | Evaluation of Alternative Polymers or Combination thereof in Comparison to Hydroxy Propyl Methyl Cellulose Acetate Succinate in the Solubility Enhancement of Poorly Soluble Drugs. | Dr. Dheeraj Nagpal | ongoing |
4 | Mr Vipresh Bhardwaj | 04-Sep-20 | Development and Evaluation of Anticancer Formulation Incorporating Phenolic Compounds from Selected Wild Berries. | Dr. Kalpana Nagpal Chaswal | ongoing |
5 | Ms Archita Katrolia | 29-Jan-21 | Design and development of Curcuma longa-Morinda citrifolia Loaded Targeted Delivery System for the Treatment of Oxidative Stress associated with Hyperglycemia. | Dr. Vikesh Kumar Shukla | ongoing |
6 | Mr Nishant Kumar Gaur | 30-Jul-21 | Development of Transdermal Drug Delivery using Targeted Drug Therapy for the Treatment of Trichophyton Verrucosum Fungal Infection. | Dr. Kalpana Nagpal Chaswal | ongoing |
7 | Ms Aanchal Arora | 30-Jul-21 | Design, Development and Characterization of Ocular in Situ Gelling System for the Therapy of Glaucom. | Dr. Neha Jain | ongoing |
8 | Mr Suryadev Sharma | 30-Jul-21 | Formulation, Characterization and Evaluation of Posaconazole Loaded Liposomes for Mucormycosis. | Dr. Dheeraj Nagpal | ongoing |
9 | Mr Bankar Anup Ramprasad | 30-Jul-21 | Development, Optimization and Characterization of the Biodegradable Polymeric System of A Model Drug for Effective Transdermal Drug Delivery System. | Dr. Indu Singh | ongoing |
10 | Ms Moumita Barman | 30-Jul-21 | Formulation and Evaluation of Nano-structured Lipid Carrier System Containing Natural Hypolipidemic Agents. | Dr. Dheeraj Nagpal | ongoing |
11 | Ms Triveni | 30-Jul-21 | Design, Optimization and Characterization of Antifungal Drug Loaded Transferosome based Hydrogels for the Management of Foot Dermatophytosis. | Dr. Neha Jain | DRC recommended for PrePhD |
12 | Ms Anjali | 29-Jan-22 | Formulation and Optimization of Nanogel based Delivery Systems for Treatment of Candida Albicans Infection | Dr. Kalpana Nagpal Chaswal | ongoing |
13 | Ms Sachan Pooja Dileepkumar | 17-Aug-22 | Design, Development & Evaluation of Phytoformulations for Treatment of Pyorrhea. | Dr. Kalpana Nagpal Chaswal | ongoing |
14 | Ms Km Reetu Malik | 17-Aug-22 | Development and Evaluation of Antimicrobial Cream of citrus Reticulata Oil. | Dr. Kalpana Nagpal Chaswal | ongoing |
15 | Ms Sarda | 17-Aug-22 | Preparation and Characterization of Vitamin E Conjugates and Its Applications. | Dr. Kalpana Nagpal Chaswal | ongoing |
16 | Ms Megha | 10-Feb-23 | DEVELOPMENT AND EVALUATION OF NOVEL DRUG DELIVERY SYSTEM OF SELECTED ANTIEPILEPTIC DRUG | Dr. Indu Singh | ongoing |
17 | Ms Nisha Khatri | 18-Sep-23 | Studies on Global Regulatory Landscape and Compliance Requirements for Radiopharmaceuticals” | Dr. Naveent Sharma | ongoing |
18 | Mr MAINUDDIN | 09-Feb-24 | to be approved by the URC | Dr. Nitin Sharma | ongoing |
19 | Mr Nitin Vig | 15-Jan-15 | Comparative Bio-Availbility Study of Fixed Dose of Generic Drug Formulation with the reference (Innovator) Formulation in Healthy Human Subjects | Dr. Shruti Chopra | Degree Awarded |
20 | Ms Divya | 16-Jan-16 | Antifungal agents loaded nanogets gor seborrheic dermatitis | Dr. Upendra Nagaich | DRC recommended for PrePhD |
21 | Mr Prashant Kumar Chaturvedi | 13-Jan-17 | Development of New or Improved Stability Indicating Liquid Chromatographic Methods and Impurity Profiling of Some Antibiotics and Antiviral Drugs | Dr. Shruti Chopra( Re-allocation of guide in process | DRC recommended for PrePhD |
22 | Mr Rajender Singh | 15-Jan-17 | Generic Drug Approval : Good Pracices of US FDAAND its Ptotential Extension to the Indian Scenario | Dr. Artiben Rameshchandra Thakkar | ODC done |
23 | Ms Anjali Dhillon | 13-Jul-18 | Development and Characterization of Polyherbal Formulation for Hypothermia | Dr. Artiben Rameshchandra Thakkar | Degree Awarded |
24 | Ms Nisha Kaushik | 13-Jul-18 | Issues and Challenges: Clinical Trials in India | Dr. Artiben Rameshchandra Thakkar | Degree Awarded |
25 | Ms Mayuri Jain | 24-Jan-20 | Design, Development and Characterization of Ethosomal Gel for the Treatment of Psoriasis. | Dr. Upendra Nagaich | ongoing |
26 | Ms Shailja | 24-Jan-20 | Design, Development and Characterization of Cubosomal Gel for the Management of Actinic Keratosis. | Dr. Upendra Nagaich | ongoing |
27 | Ms Sana | 17-Aug-22 | Comparative Evaluation of CMC (Chemistry, Manufacturing and Controls) and QMS (Quality Management System) Components of Infliximab and its Biosimilars | Dr. Sandeep Arora | ongoing |
28 | Mr Rajiv Patel | 10-Feb-23 | MODIFICATION AND EVALUATION OF SELECTED BCS CLASS-II DRUGS FOR THEIR SOLUBILITY ENHANCEMENT | Dr. Subhash Chander | ongoing |